{"database": "lobbying", "table": "lobbying_activities", "rows": [[576972, "c0dac47d-e90a-46d0-8d2e-e1d82eb33076", "YA", "BIOTECHNOLOGY INNOVATION ORGANIZATION", 6245, "BIOTECHNOLOGY INNOVATION ORGANIZATION", 2007, "year_end", "ACC", "Sarbanes-Oxley Reform\n     Section 404\n     SEC and PCAOB Guidance on Auditing Standard (AS-5)\r\nRevenue Recognition on Collaborative Agreements\n    SEC Guidance \n\nCarried Interest Tax Treatment\n     \nBiotech Capital Formation Tax Incentives/Net Operating Losses\n     H.R. 3264: American Life Sciences Competitiveness Act of 2007\n\nConvertible Debt Accounting\n    FASB Proposed Guidance", "Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),UNDETERMINED,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),White House Office", null, 3560000, 0, 0, "2008-03-12T16:27:32-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["576972"], "units": {}, "query_ms": 0.33746904227882624, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}